Rempex Pharmaceuticals

Rempex raises $67.5 million in Series B financing

Wednesday, November 9, 2011

Rempex Pharmaceuticals has completed the initial closing of a Series B financing.  New investors Frazier Healthcare Ventures and Vivo Ventures joined existing investors SV Life Sciences, OrbiMed Advisors and Adams Street Partners in committing to a total of $67.5 million for this round.  This financing, together with a previous Series A round, brings the total financing commitment for Rempex to $76 million since the company’s founding in June 2011.

[Read More]